MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

Search

10X Genomics Inc (Class A)

Închisă

SectorSănătate

7.46 -6.05

Rezumat

Modificarea prețului

24h

Curent

Minim

7.43

Maxim

7.63

Indicatori cheie

By Trading Economics

Venit

-13M

-49M

Vânzări

13M

165M

EPS

-0.136

Marjă de profit

-29.71

Angajați

1,306

EBITDA

-14M

-38M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+119.01% upside

Dividende

By Dow Jones

Următoarele câștiguri

29 apr. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

1.1B

Deschiderea anterioară

13.51

Închiderea anterioară

7.46

Sentimentul știrilor

By Acuity

100%

0%

373 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

10X Genomics Inc (Class A) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 apr. 2025, 22:38 UTC

Acțiuni populare

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

7 apr. 2025, 00:00 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Stonepeak's Total Contribution Lower Than Nominal Equity Interest Give Accelerated Spend

6 apr. 2025, 23:58 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Deal 'a Material Step' Toward Readiness for Final Investment Decision

6 apr. 2025, 23:58 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Deal 'Significantly Reduces' Company's Capex Profile

6 apr. 2025, 23:57 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Stonepeak to Contribute 75% of Project Capex in Both 2025, 2026

6 apr. 2025, 23:57 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Stonepeak to Provide $5.7 Billion Towards Expected Project Capex

6 apr. 2025, 23:57 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 apr. 2025, 23:57 UTC

Market Talk

Nervous Start For AUD/USD; Watch on CNY Fix -- Market Talk

6 apr. 2025, 23:56 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy: Signs Deal With Stonepeak for Sale of 40% Interest in Louisiana LNG Infrastructure

6 apr. 2025, 23:52 UTC

Market Talk

Gold Slips; Likely Unwinding of Long Positions to Raise Cash -- Market Talk

6 apr. 2025, 23:39 UTC

Market Talk

Oil Futures Slide on Fears of Weakening Global Demand -- Market Talk

6 apr. 2025, 23:39 UTC

Market Talk

Nikkei May Fall as U.S. Tariffs Weigh on Global Econ Outlook -- Market Talk

6 apr. 2025, 23:39 UTC

Market Talk

Global Equities Roundup: Market Talk

6 apr. 2025, 23:38 UTC

Achiziții, Fuziuni, Preluări

Challenger: Reinsurance Relationship With MS Primary Will Continue

6 apr. 2025, 23:38 UTC

Achiziții, Fuziuni, Preluări

Challenger: Acquisition at 53% Premium to Most Recent Share Price

6 apr. 2025, 23:37 UTC

Achiziții, Fuziuni, Preluări

Challenger: Acquisition Subject to Regulatory Approvals

6 apr. 2025, 23:36 UTC

Achiziții, Fuziuni, Preluări

Challenger: Dai-ichi Life Acquiring Stake From MS&AD Insurance

6 apr. 2025, 23:36 UTC

Achiziții, Fuziuni, Preluări

Challenger: Dai-ichi Life Paying About A$8.46/Share

6 apr. 2025, 23:35 UTC

Achiziții, Fuziuni, Preluări

Challenger: Dai-ichi Life Agrees to Acquire 15.1% Interest

6 apr. 2025, 21:58 UTC

Top știri

Bitcoin Is Falling Amid Global Market Swoon -- Barrons.com

6 apr. 2025, 13:00 UTC

Top știri

Trump Promised to Lower Energy Prices -- But It Wasn't Supposed to Be Like This -- WSJ

5 apr. 2025, 15:45 UTC

Top știri

Republicans Advance Trump's Tax Cuts After Late-Night Session -- Update

5 apr. 2025, 15:00 UTC

Top știri

U.S.-Stock Funds Have a Quarter to Forget -- Journal Report

5 apr. 2025, 15:00 UTC

Top știri

The Complicated Relationship Between Consumer Sentiment and Stocks -- Journal Report

5 apr. 2025, 14:38 UTC

Top știri

Trump's Trade Broadside Puts Chinese Economy Under Heavy Pressure -- WSJ

5 apr. 2025, 06:44 UTC

Top știri

Republicans Advance Trump's Tax Cuts After Late-Night Session -- WSJ

5 apr. 2025, 01:00 UTC

Achiziții, Fuziuni, Preluări

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ

5 apr. 2025, 01:00 UTC

Achiziții, Fuziuni, Preluări

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ -2-

4 apr. 2025, 21:53 UTC

Market Talk

Maxeon's Supply Chain Move at Critical Time for Solar Panel Cos -- Market Talk

4 apr. 2025, 21:44 UTC

Top știri
Achiziții, Fuziuni, Preluări

Trump Grants 75-Day Extension to Reach TikTok Deal -- 3rd Update

Comparație

Modificare preț

10X Genomics Inc (Class A) Așteptări

Obiectiv de preț

By TipRanks

119.01% sus

Prognoză pe 12 luni

Medie 16.36 USD  119.01%

Maxim 26 USD

Minim 12 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentru10X Genomics Inc (Class A) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

12 ratings

6

Cumpărare

6

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

N/A / 8.54Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Weak Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

373 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.